SOURCE: ScripsAmerica

ScripsAmerica

November 04, 2014 08:00 ET

ScripsAmerica Reports $5.6 Million in Approved Orders for Its Specialty Pharmacy in October

TYSONS CORNER, VA--(Marketwired - Nov 4, 2014) - ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $5,619,052 in approved orders during the month of October 2014, representing growth of 3% over the previous month and increasing its annual run rate to $67.4 million.

"The Company is pleased to report that approved prescription orders for Scrips' managed pharmacy continued to increase during October, representing the seventh consecutive month of growth from this segment of our business. This is a very positive start to the fourth quarter which we expect to build off of and continue to move steadily toward increasing shareholder value for our current and future investors," stated ScripsAmerica's CEO, Bob Schneiderman.

Schneiderman continued, "Main Avenue Pharmacy has also recently added key, qualified personnel that will make its overall operations more efficient and capable of facilitating continued order and revenue growth moving forward."

Additionally, ScripsAmerica would like to update its shareholders and the investment community that the the time slot when its management will present at the upcoming SeeThru Equity Conference is 10:30 AM ET on Wednesday, November 12th at the Convene Midtown East in New York City.

About ScripsAmerica, Inc.

ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information